Dian Diagnostics Group Co (SZSE:300244) GF Value : ¥22.50 (As of May. 25, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-25), Dian Diagnostics Group Co's share price is ¥13.36. Dian Diagnostics Group Co's GF Value is ¥22.50. Therefore, Dian Diagnostics Group Co's Price-to-GF-Value for today is 0.59.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Dian Diagnostics Group Co is Significantly Undervalued.

Dian Diagnostics Group Co (SZSE:300244) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Dian Diagnostics Group Co's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	13.36	/	22.50
	=	0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dian Diagnostics Group Co GF Value Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Dian Diagnostics Group Co (SZSE:300244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030

Website

http://www.dazd.cn

Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.

Executives

Chen Hai Bin	Director
Chen Shi Shi	Supervisors
Guo San Hui	Executives
Yao Shu Lie	Executives
Xu Min	Director
Wang Yan Xiao	Directors, executives
Chen Zuo Xiu	Directors, executives
Hu Yong	Director
Hu Miao Shen	Executives
Chen Xue Dong	Director
Jiang Tang	Directors, executives
Tao Jun	Securities Affairs Representative
Wu Zheng Xin	Executives
Cheng Xiu Li	Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines